Monitoring harm reduction implementation in European prisons: public health and human rights approaches

Similar documents
The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Overview of drug-induced deaths in Europe - What does the data tell us?

HIV AND PEOPLE WHO INJECT DRUGS

Smokefree Policies in Europe: Are we there yet?

New trends in harm reduction in Europe: progress made challenges ahead

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Drug laws, penalties and alternatives across Europe

Drug Consumption Rooms Worldwide

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

ECDC and Spanish Ministry of Health workshop:

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

The Misuse of Opiate Substitution Therapy: an Obstacle for the Diffusion of Best Practice in Italy Lisbon, 23 September 2015

Horizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe

INTRAVENOUS INJECTING DRUG USE.

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

The impact of economic recession on drug users and drug treatment

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Market surveillance of medical devices

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Underage drinking in Europe

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Technical Guidance Note for Global Fund HIV Proposals

United Nations Office on Drugs and Crime (UNODC)

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

Harm Reduction in Nigeria

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

HIV/AIDS Joint Action HA-REACT

EUVAC.NET A surveillance network for vaccine-preventable diseases

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

Engagement in language assessment / Regions of Europe

Statistical Table 17: Prevalence of hepatitis C infection among injecting drug users under age 25 in the EU (%) (sample sizes between brackets)

Screening for Cervical Cancer in Europe

Identifying Common Ground on Public Health for UNGASS 2016:

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

HIV testing in Europe: From policy to effectiveness

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

WCPT COUNTRY PROFILE December 2017 SWEDEN

Alcohol Prevention Day

Trends in injecting drug use in Europe

WCPT COUNTRY PROFILE December 2017 HUNGARY

Hearing Loss: The Statistics

WCPT COUNTRY PROFILE December 2017 SERBIA

Statistical Table 13: Prevalence of HIV infection (%) among injecting drug users under age 25, in the EU (sample sizes between brackets)

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Project Meeting Prague

HIV/AIDS, STI, hepatitis

COMMISSION OF THE EUROPEAN COMMUNITIES

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

COUNTRY TABLE. MONTENEGRO.

Present and potential perspectives for information on alcohol use in the EU

Co-ordination, monitoring and evaluation of drug policies. Bob Keizer. Senior Drug Policy Advisor. Trimbos-instituut

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

Introduction. Information for the Committee s consideration

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover

ADDRESSING LEGAL AND POLICY BARRIERS. To Effective HIV Prevention

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Models of good practice in drug treatment in Europe. Project group

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Mid study Advisory Group Meeting, 14 th February 2011

European status report on alcohol and health Leadership, awareness and commitment

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX

Public health dimension of the world drug problem

Alcohol-related harm in Europe and the WHO policy response

Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena

Female genital mutilation: estimating girls at risk. Jurgita Peciuriene

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Government of Malawi. SUMMARY of the National Plan of Action to Combat Gender-Based Violence in Malawi

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Statement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

LEBANON. WCPT COUNTRY PROFILE December 2018

HIV in Prison Situation in Frankfurt am Main

Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union

Intervention from the World Health Organization

Project BISTAIRS. Deliverable 1b (Work Package 4)

Risk perception and food safety: where do European consumers stand today?

European Community Pharmacy: a reference in Public Health

Many countries in EECA substantially rely on international funding to tackle HIV and TB, and

DENMARK. WCPT COUNTRY PROFILE December 2018

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Nutrient profiles for foods bearing claims

1/5 of world s population 40% of world s poor 400 million < USD 1/day >11 million drug users & > 3.6 million opiate users

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Transcription:

Monitoring harm reduction implementation in European prisons: public health and human rights approaches Cinzia Brentari, Harm Reduction International ~ 14 June 2015 ~ cinzia.brentari@ihra.net www.ihra.net

ABOUT US: HARM REDUCTION INTERNATIONAL HRI is London based leading non-governmental organisation working to reduce the negative health, social and human rights impacts of drug use and drug policy by promoting evidence-based public health policies and practices, and human rights based approaches to drugs.

WHATWEDO Evidence and Advocacy Research and policy analysis informing advocacy across our sector: The Global State of Harm Reduction Funding for Harm Reduction Human rights based policy Human rights abuses and drug enforcement go hand in hand. HRI challenges laws, policies and practices that generate harm. International conferences Harm reduction is a global movement. Sector strengthening HRI builds advocacy coalitions and supports emerging harm reduction networks to strengthen the international harm reduction sector. - Coordinating the European Harm Reduction Network, www.eurohrn.eu

GLOBAL AVAILABILITY OF NEEDLE AND SYRINGE PROGRAMMES

GLOBAL AVAILABILITY OF OPIOID SUBSTITUTION PROGRAMMES

A PUBLIC HEALTH APPROACH TO INFECTIOUS DISEASES PREVENTION IN PRISON PRIDE EUROPE STUDY - Objective: Analise the levelsof adherenceon harmreductionservices in prisons to national and international guidelines questionnaire to all prisons medical doctors (UNODC 2012 HIV Prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions and WHO/UNODC/UNAIDS 2007 Effectiveness of interventions to address HIV in prison ) Geographical coverage, 4 EU states: Belgium: 35 prisons. Research by the Prison Administration and Ghent University Austria: 28 prisons. Research by the Prison Administration Italy: 205 prisons. Research by FederSerD, Denmark: 49 prisons, Centre for Alcohol and Drug Research, Aarhus University Co- funded by the EU

PRIDE EUROPE: AREAS INVESTIGATED

PRIDE EUROPE: AREAS INVESTIGATED

Total adherence score to international recommendations Max Maximum adherence level:12 IQR 75% Médiane Moyenne All countries scoring only between 3.5 and 4.5 IQR 25% Min

A HUMAN RIGHTS APPROACH TO INFECTIOUS DISEASES PREVENTION IN PRISON Several human rights conventions enshrine prisoners rights, including their right to the highest attainable standard of health (UDHR, ICCPR, ICESCR, CAT, ECHR, etc.) Standards relating to prisoners health have been set by human rights and public health bodies International, regional and national human rights monitoring mechanisms have been put in place to ensure compliance with those conventions and standards, and to ultimately protect prisoners rights (SPT, CPT, NPMs ). Generally grounded in the prevention of torture and ill treatment, their mandates do encompass health issues and rights. The European Court of Human Rights also has growing body of case law of prisoners rights, including health rights.

IMPROVING PRISON CONDITIONS BY STRENGTHENING INFECTIOUS DISEASE MONITORING A HRI PROJECT Objective: reduce ill-treatment of persons in detention and improve prison conditions through enhanced and standardised monitoring and inspection mechanisms on infectious diseases (TB, HIV and HCV). Develop a user-friendly tool to generate better informed, more consistent, and sustained human rights monitoring of infectious diseases in prisons by national, regional and international human rights monitoring mechanisms. Working at European level with specific mapping and advocacy work in Greece, Ireland, Italy, Latvia, Portugal, Poland, Spain This project is co-funded by the European Union under the Criminal Justice Programme

IN SUMMARY Things we already know Things we need to do Increase civil society engagement and networks of people who use drugs in research Strategise on how best to gather data in key populations/areas Ensure independent mechanism for gathering global data

THANK YOU For information: Cinzia Brentari, project manager, HRI Cinzia.brentari@ihra.net www.ihra.net